Axumin (Blue Earth Diagnostics)


Welcome to the PulseAid listing for the Axumin drug offered from Blue Earth Diagnostics. This Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Blue Earth Diagnostics
NON-PROPRIETARY NAME: Fluciclovine F-18
SUBSTANCE NAME: FLUCICLOVINE F-18
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-05-27
END MARKETING DATE: 0000-00-00


Axumin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAxumin from Blue Earth Diagnostics
LABELER NAME: Blue Earth Diagnostics
DEA SCHEDULE:
ACTIVE STRENGTH: 221(mCi/mL)
START MARKETING DATE: 2016-05-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69932-001_982e43f0-16d2-43fd-97d4-6c9a3db8b819
PRODUCT NDC: 69932-001
APPLICATION NUMBER: NDA208054

Other FLUCICLOVINE F-18 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Blue Earth DiagnosticsAxumin